Bluejay Diagnostics Inc (BJDX : NASDAQ)
Common Stock
$2.12
USD
+1.56 (281.02%)
Last updated: 2026-11-02
Follow BJDX
BJDX
Bluejay Diagnostics Inc
WealthAwesomePerformance
1 Day
+281.02%
1 Week
+278.50%
1 Month
+153.29%
YTD
-52.25%
Key Statistics
Market Cap
$2.49M
52W High
$28.32
52W Low
$1.84
P/E Ratio
-
50 Day MA
$0.82
200 Day MA
$1.85
Beta
0.89
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/2/2026 | $2.10 | $2.32 | $2.00 | $2.12 | $2.12 | 43,814 |
| 10/30/2026 | $0.53 | $0.60 | $0.46 | $0.56 | $0.56 | 280,946 |
| 10/29/2026 | $0.58 | $0.58 | $0.52 | $0.54 | $0.54 | 97,897 |
| 10/28/2026 | $0.58 | $0.60 | $0.56 | $0.57 | $0.57 | 38,990 |
| 10/27/2026 | $0.57 | $0.62 | $0.57 | $0.58 | $0.58 | 33,576 |
| 10/26/2026 | $0.59 | $0.60 | $0.56 | $0.56 | $0.56 | 98,026 |
| 10/23/2026 | $0.63 | $0.65 | $0.58 | $0.58 | $0.58 | 43,800 |
| 10/22/2026 | $0.69 | $0.70 | $0.62 | $0.63 | $0.63 | 31,643 |
| 10/21/2026 | $0.67 | $0.71 | $0.67 | $0.68 | $0.68 | 31,600 |
| 10/20/2026 | $0.68 | $0.69 | $0.67 | $0.67 | $0.67 | 47,748 |
Analyst Price Targets
Based on analyst covering BJDX · as of Sep 17, 2026
Wall Street analysts forecast BJDX stock price to rise 11975.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
US$256.00
+11975.5% Upside
Current Price
US$2.12
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BJDX's historical volatility
30-Day Vol
399.1%
Annualized
90-Day Vol
280.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$2.53
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$2.25 | US$0.57 – US$8.92 |
| 60 trading days | US$2.39 | US$0.34 – US$16.74 |
| 90 trading days | US$2.53 | US$0.23 – US$27.53 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Bluejay Diagnostics Inc
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-7.24M
- Profit Margin
- 0.00%
- ROE (TTM)
- -98.89%
- EPS (Diluted)
- -3.58
- Book Value
- 4.75
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About BJDX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| VCIG | VCI Global Limited Ordinary Share | $8.16 | +4728.40% |
| RETO | ReTo Eco-Solutions Inc | $4.16 | +647.26% |
| INO | Inovio Pharmaceuticals Inc | $1.89 | +215.00% |
| CLRO | ClearOne Inc | $5.65 | +65.69% |
| INLF | INLIF LIMITED Ordinary Shares | $0.29 | +56.76% |
| AMPGZ | Amplitech Group, Inc. Series B Right | $0.06 | +55.50% |
| GENVR | Gen Digital Inc. Contingent Value Rights | $2.85 | +52.41% |
| RDACR | Rising Dragon Acquisition Corp. Rights | $0.12 | +47.97% |